bucladesine has been researched along with Rhabdomyosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavenee, WK; Huang, HJ; Newsham, I; Wasserman, LM | 1 |
| O'Neill, FJ | 1 |
| Dexter, DL | 1 |
3 other study(ies) available for bucladesine and Rhabdomyosarcoma
| Article | Year |
|---|---|
cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
Topics: Acetylcholinesterase; Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Humans; Microtubule-Associated Proteins; Muscle Proteins; Muscle, Skeletal; Myogenic Regulatory Factors; Myosin Light Chains; Rhabdomyosarcoma; RNA, Messenger; Tumor Cells, Cultured | 1996 |
Limitation of multinucleation by dibutyryl adenosine 3',5'-cyclic monophosphate in tumor cells treated with cytochalasin B.
Topics: Animals; Bucladesine; Cell Line; Cell Nucleus; Cell Survival; Cells, Cultured; Cricetinae; Cytochalasin B; Neoplasms, Experimental; Rhabdomyosarcoma; Theophylline | 1976 |
N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Division; Cell Survival; Cells, Cultured; Dimethylformamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rhabdomyosarcoma; Sarcoma, Experimental; Transplantation, Homologous | 1977 |